The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Allograft versus non-allograft post-transplant lymphoproliferative disorder, characterization of two distinct subtypes as defined by presentation, histology, and outcome: A case series of 165 patients.
D. E. Tsai
No relevant relationships to disclose
I. S. Hagemann
No relevant relationships to disclose
J. J. Morrissette
No relevant relationships to disclose
R. Daber
No relevant relationships to disclose
D. Xu
No relevant relationships to disclose
S. J. Schuster
No relevant relationships to disclose
R. D. Bloom
No relevant relationships to disclose
V. N. Ahya
No relevant relationships to disclose
M. Jessup
No relevant relationships to disclose
G. A. Makar
No relevant relationships to disclose
S. Chen
No relevant relationships to disclose
R. Reshef
No relevant relationships to disclose